liver (7) , and hepatic parenchymal cells may remove chylomicrons by pinocytosis (8) . Extrahepatic tissues are capable of removing TGFA of chylomicrons from the blood (9) and under ordinary conditions are probably the chief sites of removal (5) . Extrahepatic uptake of such TGFA is related to the local activity of lipoprotein lipase (10) . The liver appears to be the chief site of removal of chylomicron cholesterol from the blood. Biggs (11) injected chyle containing HW-cholesterol intravenously in rats and recovered about 80% of the label in the liver 30 minutes later.
This finding suggests that uptake of chylomicron TGFA occurs in extrahepatic tissues without concurrent uptake of chylomicron cholesterol. The possibility, however, that intact chylomicrons may enter adipose tissue by a process of pinocytosis has been advanced on the basis of in zitro incubation studies (12) .
This report presents the results of experiments in which the different lipids in chylomicrons were labeled with separate isotopes and injected into both intact and functionally hepatectomized dogs. The rate of removal of the various lipids from plasma and their incorporation into various tissues was then determined.
METHODS
Preparation of labeled chylomicrons. For the experiments on dogs 1, 2, 4, and 5, TGFA, ester cholesterol, and free cholesterol in the chylomicrons were labeled by feeding donor dogs 500 ,uc of sodium palmitate-9,10-HW and 50 uc of cholesterol-4-C1' with milk. For the other experiments, the phospholopids in the chylomicrons were also labeled by iv injection of 5 mc of sodium phosphate Pa into donor dogs 4 hours before feeding the other isotopes. Lymph was obtained from the donor dogs through a cannula inserted in the thoracic duct. The chylomicrons were separated by layering the lymph under 0.15 M NaCI. After centrifugation for 30 minutes at 20,000 rpm in the 30 rotor of a Spinco model L ultracentrifuge, the supernatant fluid was separated by means of a tube slicer. The chylomicrons were collected and resuspended in saline. (vol/ vol) . One-fifth vol of 0.02 N HCl was added to produce a two-phase system. The lipids of the chloroform phase were separated into three fractions on silicic acid columns (13) . Samples of fraction 1, which contained cholesterol esters, were assayed for radioactivity. Fraction 2 contained triglycerides, free cholesterol, and in the extracts from the infranatant fractions, free fatty acids. The latter were separated from the neutral lipids by the method of Borgstr6m (14) . Samples of the neutral lipid fractions were assayed for H3-(TGFA) and C14-(free cholesterol) radioactivity. Pr-radioactivity was measured in phospholipids (fraction 3) when this fraction was labeled. All fractions were dissolved in toluene containing 0.3% diphenyloxazole and assayed for radioactivity in a Packard Tri-Carb liquid scintillation spectrometer. Tritium and C4-radioactivity in fraction 2 were assayed simultaneously (15) .
Extracts containing hepatic lipids were treated similarly. Radioactivity associated with TGFA, free cholesterol, and ester cholesterol in adipose tissue was measured in the extracts as follows. Tritium and C14-radioactivity were measured in one sample to determine TGFA and total cholesterol radioactivity, respectively. Free cholesterol was precipitated as the digitonide from another sample, redissolved in methanol, and assayed for C`4-radioactivity. Quenching was measured with an internal standard. Radioactivity in ester cholesterol was calculated by difference.
RESULTS

Intact dogs (no. 1-5)
The rates of removal from the chylomicron fraction of plasma of the radioactivity in TGFA, ester cholesterol, and free cholesterol moieties of the infused chyloinicrons are shown in Table I . In dogs 2 ( Figure 1 ) and 3, radioactivity in all three fractions was removed at similar rates. In dogs 1, 4, and 5, the rate of removal of radioactivity in TGFA was faster than that in ester cholesterol and free cholesterol, but this difference was pronounced only in dog 5. The radioactivity in TGFA, ester cholesterol, and free cholesterol in the samples of liver was calculated for each time interval after injection. In Table II these data are expressed as the percentage of the initially injected radioactivity that had left the plasma chylomicron compartment (see Figure 1) . No Functionally hepatectomized dogs Complete hepatic exclusion (dog 6). In this animal, the circulation to the liver was totally interrupted at a single operation immediately before the infusion of chylomicrons. The rates of disappearance of radioactivity from the four lipid moieties of the chylomicron fraction of plasma from dog 6 are shown in Figure 3 and expressed as half-times in Table I . The rates of removal were considerably slower than those in the five intact dogs. Radioactivity associated with ester cholesterol and free cholesterol was removed very slowly; radioactivity in TGFA and phospholipids was removed much more rapidly. No radioactivity was found in the sample of liver taken at the end of the experiment.
Samples of omental adipose tissue obtained at the end of the experiment contained 40% of the small amount of radioactivity associated with the cholesterol fractions removed from plasma chylomicrons. The radioactivity was evenly divided between the ester cholesterol and the free cholesterol fractions, although the ratio of the two fractions in the infused chylomicrons was 2: 1.
About 40%o of the radioactivity in TGFA removed from plasma was also present in the adipose tissue.
Partial hepatic exclusion (dogs 7 and 8). In these two animals, portacaval anastomoses were performed 10 weeks before the infusion of chylomicrons, which were injected immediately after the portal vein and hepatic artery were clamped. The color of the liver had indicated that the circulation had been successfully interrupted; nevertheless, one-quarter of the total cholesterol radioactivity removed from the chylomicron fraction of plasma during the first 30 minutes was found in the liver.
During hepatic exclusion in both dogs, the radioactivity associated with the phospholipid fraction was removed from plasma chylomicrons most rapidly ( Figure 4 and Table I ). TGFA radioactivity disappeared from the chylomicron fraction of plasma more rapidly than radioactivity associated with free cholesterol and considerably more rapidly than that associated with ester cholesterol. After the clamps were removed from the hepatic artery and portal vein, the rates of disappearance of radioactivity in all four fractions increased, particularly in that associated with ester cholesterol. In both dogs, comparison of the concentration of radioactivity in the samples of liver obtained before the clamps were released and at the end of the experiment showed that approximately three-quarters of the cholesterol radioactivity found in the liver at the end of the experiment had been removed after restoration of the hepatic circulation. At that time, the liver contained about half the radioactivity removed from the plasma chylomicrons.
From the concentration of radioactivity in samples of adipose tissue taken at the end of the experiment, it was calculated that a third of cholesterol radioactivity removed from plasma chylomicrons had been deposited in adipose tissue.
METABOLISM OF CONSTITUENT LIPIDS OF DOG CHYLOMICRONS
DISCUSSION
The rate of removal of radioactivity was determined in five intact dogs after injection of chylomicrons in which the different lipid components had been individually labeled (Table I) . In two dogs, radioactivity in TGFA, ester cholesterol, and free cholesterol was removed from the circulation at similar rates. In the other three animals, radioactivity in TGFA was removed slightly faster (two dogs) or considerably faster (one dog) than the radioactivity in ester cholesterol and free cholesterol.
Conversely, in the one experiment (dog 6) in which the liver was entirely excluded from the circulation, cholesterol radioactivity, and in particular, that associated with ester cholesterol, was removed from plasma chylomicrons very slowly ( Figure 3) ; radioactivity in TGFA and phospholipids was removed considerably more rapidly. The relatively slow removal of TGFA in this dog may have resulted from reduced perfusion of tissues, since the blood pressure was only about 80 mm Hg.
In the two dogs in which the liver was only partly excluded from the circulation, probably owing to the presence of collateral vessels at the diaphragmatic surface, the findings were less conclusive. Nevertheless, the removal of radioactivity in ester cholesterol was considerably slower than that in TGFA; in this respect, the findings in these partially hepatectomized dogs differ from those in four of the five normal dogs.
These findings are consistent with the high rate of incorporation of cholesterol radioactivity into hepatic cholesterol in the intact dogs (Table II) . At least 70% of the ester cholesterol radioactivity and 77%o of the free cholesterol radioactivity removed from plasma chylomicrons were recovered in the liver. Therpfore, in intact dogs the liver appears to be the major site of removal of chylomicron cholesterol. This is in agreement with similar observations in the rat by Biggs (11) and by Borgstr6m, Lindhe, and Wlodawer (16) , who were able to recover the greater part of an orally administered load of labeled cholesterol in the liver. After the completion of our experiments, Lossow, Brot, and Chaikoff (17) and Goodman (18) published the results of studies in the rat that confirm and extend Biggs's findings. They also found 6 to 18%o (17) and 1 to 3% (18) of the cholesterol in adipose tissue 10 to 20 minutes after injection of chylomicrons labeled with C14-cholesterol.
In our intact animals, about 5% of the radioactivity associated with the cholesterol removed from plasma chylomicrons in 15 to 30 minutes was present in adipose tissue. This could have been derived from contaminating plasma chylomicrons or from other plasma lipoproteins becoming labeled either in the liver, or by direct transfer or exchange of cholesterol within the plasma compartment.
The mechanism involved in extrahepatic uptake of chylomicron cholesterol is uncertain. The liver is not essential for this process, since it occurred il the hepatectomized dog. This process is apparently less efficient that that responsible for uptake of TGFA. In the functionally hepatectomized animals, the rate of removal of TGFA radioactivity was considerably more rapid than that of ester cholesterol. In the intact dog, extrahepatic tissues have a major role in removal of chylomicron TGFA from the blood; two-thirds of the radioactivity associated with TGFA was found to be removed directly by extrahepatic routes when moderate amounts of triglyceride were continuously infused at a slow rate (5) . In the present experiments in which large amounts of lipid. were injected as a single dose, more TGFA radioactivity was found in the liver than when less lipid was delivered by slow, constant infusion. Nevertheless, less radioactivity in TGFA than in. cholesterol was recovered in the liver of intact dogs (Table II) , suggesting more extensive removal by extrahepatic tissues of TGFA than of cholesterol.
The more rapid removal of TGFA than of ester cholesterol radioactivity in three normal dogs was probably related to more extensive extrahepatic uptake of TGFA. This is supported by the findings in the first two dogs in which samples of liver were obtained early in the experiment. In dog 1, radioactivity in TGFA was removed more rapidly than that in ester cholesterol; in dog 2, the rates of removal were similar. In samples of liver obtained 15 minutes after the injection of chylomicrons, 35% of the radioactivity removed from plasma TGFA was found in the liver of dog 1, whereas 75%o was present in the 1319 liver of dog 2. In contrast, 84 and 78% of the radioactivity removed from the plasma ester cholesterol of the two dogs after 15 minutes was recovered in the corresponding samples of liver. Moreover, at the end of 1 hour, 21% of the radioactivity removed from chylomicron TGFA was recovered in the adipose tissue of dog 1, but only 10% in dog 2. In both, 10% of the total infused cholesterol radioactivity was present in adipose tissue at the end of 1 hour. It appears, therefore, that when chylomicron removal occurs primarily in the liver, the TGFA and ester cholesterol moieties of chylomicrons are removed at similar rates. TGFA, however, are removed more rapidly than ester cholesterol when extrahepatic tissue participates more extensively in the removal of TGFA.
p32 was consistently removed from the chylomicron fraction of plasma at a rate comparable to that of radioactivity in TGFA. The similar rates cannot be taken to suggest a similar mechanism for removal, since a large fraction of the injected p32 was rapidly transferred to higher-density lipoproteins. This finding agrees with the earlier observation by Havel and Clarke (3) of the rapid exchange of p32 in chylomicron phospholipids with those of higher-density lipoproteins upon incubation in vitro.
On the basis of our data and other available evidence, the most probable mechanism for removal of chylomicrons from the blood is as follows. In extrahepatic tissues, part of the triglyceride moiety is removed, probably after prior hydrolysis, and uptake of intact chylomicrons is limited. In the liver, intact chylomicrons and chylomicrons from which variable quantities of triglycerides have been removed are taken up intact into the parenchymal cells, presumably by pinocytosis.
SUMMARY
The metabolism of the individual lipid constituents of chylomicrons was studied in the dog. Chylomicrons in which the different lipids had been labeled by separate isotopes were injected intravenously into five normal dogs. The radioactivity in triglyceride fatty acids, ester cholesterol, and free cholesterol was removed from the chylomicron fraction of plasma lipids at similar rates in two animals. Radioactivity in the cholesterol fractions was removed slightly more slowly in two of the remaining three animals and considerably more slowly in the third. In a single experiment in which phospholipids were also labeled, radioactivity in phospholipids was removed at a rate similar to that in triglyceride fatty acids.
When similarly labeled chylomicrons were infused into dogs in which the liver was either completely or partially excluded from the circulation, radioactivity was removed considerably more slowly in the cholesterol fractions than in the triglyceride fatty acids or phospholipids.
In normal dogs, the liver removed almost all the infused chylomicron cholesterol radioactivity, but only a smaller and variable fraction of the triglyceride fatty acid radioactivity. In the functionally hepatectomized dogs, about one-third of the radioactivity removed from chylomicron cholesterol was recovered in adipose tissue.
The mechanisms of uptake of chylomicron constituents in liver and extrahepatic tissues are discussed in light of this information.
